Fig. 6.

Final results of the voting on case scenario 5, older patients (≥65 years of age) with psoriasis. a denotes P < 0.01 compared with MTX therapy; b denotes P < 0.01 compared with TNFI-etanercept preferred therapy; c denotes P < 0.05 compared with TNFI-adalimumab preferred therapy; d denotes P < 0.05 compared with acitretin therapy; e denotes P < 0.05 compared with etanercept therapy. MTX methotrexate; pref preferred; TNFI tumor necrosis factor inhibitor; UV ultraviolet; UVB-NB narrowband ultraviolet B therapy